Sophia Genetics
Earnings Roundup: OraSure Technologies, Opko Health, Biodesix, Sophia Genetics,
OraSure, Opko, Sophia Genetics, and Biodesix reported their third quarter financial results this week.
Sophia Genetics, Memorial Sloan Kettering, AstraZeneca Partner to Broaden Cancer Sequencing Access
The companies aim to create a decentralized global network for genomic cancer testing, including underserved regions where access remains limited.
Sophia Genetics Q2 Revenue Grows 29 Percent as Analysis Volume Takes Off
Sophia Genetics narrowed its net loss to $21.4 million during Q2 but narrowly missed Wall Street revenue and bottom-line expectations.
Sophia Genetics Q4 Revenues Grow 23 Percent on Strong Data Analysis Sales
Sophia also issued its first guidance for 2023, expecting revenue growth of at least 30 percent this year.
JP Morgan Healthcare Conference, Day 2: Labcorp, Abbott, Thermo Fisher Scientific, Roche, More
Highlights from the first day included updates on several firms' COVID testing businesses, and details about a recent Thermo Fisher Scientific acquisition.
May 11, 2022
May 10, 2022
Sophia Genetics Q1 Revenues Increase 21 Percent
Nov 10, 2021
Sophia Genetics Q3 Revenues Increase 44 Percent
Sep 9, 2021
Sophia Genetics Q2 Revenue Grows 72 Percent
Jul 19, 2021